Transcriptomics

Dataset Information

0

In vivo growth of subclones derived from Lewis lung carcinoma is determined by the tumor microenvironment not intrinsic proliferative ability


ABSTRACT: Heterogeneity is a fundamental feature of human tumors and plays a major role in drug resistance and disease progression. In the present study, we selected single-cell-derived cell lines (SCDCLs) derived from Lewis lung carcinoma (LLC1) cells to investigate tumorigenesis and heterogeneity. SCDCLs were generated using limiting dilution. Five SCDCLs were subcutaneously injected into wild-type C57BL/6N mice; however, they displayed significant differences in tumor growth. Subclone SCC1 grew the fastest in vivo, whereas it grew slower in vitro. The growth pattern of SCC2 was the opposite to that of SCC1. Genetic differences in these two subclones showed marked differences in cell adhesion and proliferation. Pathway enrichment results indicate that signal transduction and immune system responses were the most significantly altered functional categories in SCC2 cells compared to SCC1 cells in vitro. The number and activation of CD3+ and CD8+ T cells and NK cells in the tumor tissue of tumor-bearing mice inoculated with SCC2 were significantly higher, whereas those of myeloid cells were significantly lower, than those in the SCC1 and LLC1 groups. Our results suggest that the in vivo growth of two subclones derived from LLC1 was determined by the tumor microenvironment rather than their intrinsic proliferative cell characteristics.

ORGANISM(S): Mus musculus

PROVIDER: GSE216396 | GEO | 2023/10/23

REPOSITORIES: GEO

Similar Datasets

2015-06-05 | E-GEOD-68573 | biostudies-arrayexpress
2018-07-17 | GSE106182 | GEO
2019-06-06 | GSE132221 | GEO
2016-02-18 | GSE76890 | GEO
2014-10-21 | E-GEOD-62493 | biostudies-arrayexpress
2016-02-18 | E-GEOD-76890 | biostudies-arrayexpress
2022-06-18 | GSE206003 | GEO
2022-06-18 | GSE206000 | GEO
2019-12-01 | GSE128930 | GEO
2022-05-25 | GSE201193 | GEO